Related Experiment Video

Updated: Jun 18, 2025

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.1K

The cGAS/STING Pathway-A New Potential Biotherapeutic Target for Gastric Cancer?

Mengxiang Tian1,2, Shuai Zhang1, Fengbo Tan1,2

  • 1Department of General Surgery, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410017, China.

Journal of Personalized Medicine
|July 27, 2024
PubMed

Insights

Gastric cancer biotherapy shows promise by targeting the cGAS-STING pathway. This innate immune pathway can convert immunosuppressive tumor environments into immune-stimulating ones, offering new hope against this deadly cancer.

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Background:

  • Gastric cancer is a leading cause of cancer death globally, with current treatments often proving insufficient.
  • Tumor microenvironments can suppress immune responses, necessitating novel therapeutic strategies like biotherapy.
  • The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway is a key innate immune sensor for aberrant DNA.

Purpose of the Study:

  • To review the current research on the cGAS-STING pathway in gastric cancer.
  • To evaluate the potential of targeting the cGAS-STING pathway for gastric cancer biotherapy.
  • To discuss clinical trial insights regarding STING agonists in gastric cancer.

Main Methods:

  • Literature review of scientific publications and clinical trial data.
  • Analysis of the role of the cGAS-STING pathway in innate immunity and cancer.
  • Assessment of biotherapeutic strategies involving the cGAS-STING pathway.

Main Results:

  • The cGAS-STING pathway recognizes tumor-derived DNA and initiates immune responses.
  • Activating the cGAS-STING pathway can transform the immunosuppressive tumor microenvironment into an immune-stimulatory one.
  • Early clinical trials show potential for STING agonists in cancer treatment.

Conclusions:

  • The cGAS-STING pathway represents a promising target for novel gastric cancer biotherapeutics.
  • Harnessing this pathway could overcome resistance to conventional therapies and immunotherapy.
  • Further research and clinical trials are warranted to fully realize the therapeutic potential of cGAS-STING agonists in gastric cancer.
Keywords:
cGAS-STINGcancer biotherapygastric cancerinnate immune responsetumor immunosuppressive microenvironment

More Related Videos

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.4K
Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells09:24

Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells

Published on: May 9, 2020

4.4K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
296
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.4K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
558
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
157
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K